BIO
Amy Pace, ScD
Vice President, Biostatistics
As Vice President of Biostatistics Consulting at Parexel, Amy is responsible for advising on the planning and execution of biostatistics services in all phases of drug and device development, including regulatory interactions and submissions.
Work Experience
Amy has been in the industry for more than 20 years. Her expertise encompasses optimizing trial design, deep knowledge of various statistical models and applications, and a thorough understanding of potential issues in clinical trials and strategies to avoid them. She has extensive experience in Phase I–IV drug development in the pharmaceutical/biotech industry, including regulatory interactions in the EU, North America, and Japan.
Education
Amy holds a ScD in biostatistics from Harvard T.H. Chan School of Public Health.